182 related articles for article (PubMed ID: 6950815)
1. Modification of growth and differentiation of myeloid leukemia cells by tumor promoters.
Hozumi M; Kasukabe T; Honma Y
Carcinog Compr Surv; 1982; 7():379-84. PubMed ID: 6950815
[TBL] [Abstract][Full Text] [Related]
2. The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate inhibits or enhances induction of differentiation of mouse myeloid leukemia cells depending on the type of serum in the medium.
Kasukabe T; Honma Y; Hozumi M
Gan; 1981 Apr; 72(2):310-4. PubMed ID: 6945282
[TBL] [Abstract][Full Text] [Related]
3. Modification by serum of differentiation of cultured human myeloid leukemia cells in response to 12-O-tetradecanoylphorbol-13-acetate.
Honma Y; Kasukabe T; Hozumi M
Gan; 1982 Feb; 73(1):97-104. PubMed ID: 6956528
[TBL] [Abstract][Full Text] [Related]
4. Enhancing effect of phorbol esters on induction of differentiation of mouse myeloid leukemia cells by human urinary protein and lipopolysaccharide.
Nakayasu M; Shoji M; Aoki N; Sato S; Miwa M; Sugimura T
Cancer Res; 1979 Nov; 39(11):4668-72. PubMed ID: 291479
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of functional and morphological differentiation of cultured mouse myeloid leukemia cells by tumor promoters.
Kasukabe T; Honma Y; Hozumi M
Gan; 1979 Feb; 70(1):119-23. PubMed ID: 286666
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of differentiation of mouse myeloid leukemia cells by heat-stable calf serum components of very high molecular weight.
Kasukabe T; Honma Y; Hozumi M
Leuk Res; 1982; 6(5):695-702. PubMed ID: 6961266
[TBL] [Abstract][Full Text] [Related]
7. Dependence of cytokine-induced human myelogenous leukemic cell differentiation on the type of serum in the medium.
Sakagami H; Ikeda M; Fukushima Y; Konno K
Anticancer Res; 1990; 10(2A):385-90. PubMed ID: 2111976
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1985 Oct; 45(10):4848-52. PubMed ID: 3861237
[TBL] [Abstract][Full Text] [Related]
9. Characterization of factors stimulating differentiation of mouse myeloid leukemia cells from a Yoshida sarcoma cell line cultured in serum-free medium.
Hozumi M; Umezawa T; Takenaga K; Ohno T; Shikita M; Yamane I
Cancer Res; 1979 Dec; 39(12):5127-31. PubMed ID: 315274
[TBL] [Abstract][Full Text] [Related]
10. Increased glucocorticoid receptor concentration in macrophage differentiation of myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate.
Hirai H; Murakami T; Urabe A; Takaku F
Cancer Res; 1985 Jun; 45(6):2456-61. PubMed ID: 3857120
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by retinoic acid of prostaglandin production and its inhibition by tumor promoters in mouse myeloid leukemia cells.
Takenaga K
Gan; 1981 Aug; 72(4):488-97. PubMed ID: 6946953
[TBL] [Abstract][Full Text] [Related]
12. Effect of tunicamycin on production by mouse fibroblast L929 cells of the factor-stimulating differentiation of mouse myeloid leukemic cells and the colony-stimulating factor.
Yamamoto Y; Tomida M; Hozumi M; Ayusawa D; Seno T; Tamura G
Cancer Res; 1981 Jun; 41(6):2534-9. PubMed ID: 6972252
[TBL] [Abstract][Full Text] [Related]
13. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748
[TBL] [Abstract][Full Text] [Related]
14. Effect of 12-O-tetradecanoylphorbol-13-acetate on the morphology and growth of C3H/10T1/2 mouse embryo cells.
Boreiko C; Mondal S; Narayan KS; Heidelberger C
Cancer Res; 1980 Dec; 40(12):4709-16. PubMed ID: 7438102
[TBL] [Abstract][Full Text] [Related]
15. Regulation of growth and differentiation by phorbol esters and the mechanism of tumor promotion.
Lotem J; Sachs L
Carcinog Compr Surv; 1982; 7():385-90. PubMed ID: 6978180
[TBL] [Abstract][Full Text] [Related]
16. Initiator and promoter induced specific changes in epidermal function and biological potential.
Yuspa SH; Hennings H; Lichti U
J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
[TBL] [Abstract][Full Text] [Related]
17. Tumor promoter-mediated effects on Friend leukemia cells induced by actinomycin D: flow microfluorometry analysis and erythroid differentiation.
Gambari R
Basic Appl Histochem; 1982; 26(3):163-72. PubMed ID: 7138458
[TBL] [Abstract][Full Text] [Related]
18. The production of differentiation autoinducing activity by WEHI-3B D+ leukemia cells.
Kajigaya Y; Ikuta K; Sasaki H; Funabiki T; Koiso Y; Matsuyama S
Exp Hematol; 1989 May; 17(4):368-73. PubMed ID: 2785052
[TBL] [Abstract][Full Text] [Related]
19. [Differentiation of human normal and leukemic bone marrow and blood cells in tissue culture upon exposure to a tumor promotor].
Svet-Moldavskiĭ GIa; Khollend JF; Svet-Moldavskiĭ IA; Clarkson BD
Dokl Akad Nauk SSSR; 1979; 249(3):720-2. PubMed ID: 294343
[No Abstract] [Full Text] [Related]
20. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
